Can colchicine be used to treat musculoskeletal pain?

Colchicine for Musculoskeletal Pain

Colchicine is NOT recommended for general musculoskeletal pain—it is specifically indicated only for gout flares and familial Mediterranean fever (FMF), not for non-specific musculoskeletal pain. 1, 2

Evidence-Based Indications

The FDA-approved indications for colchicine are limited and specific 2:

• Gout flares (acute crystal-induced arthritis)
• Familial Mediterranean fever

Colchicine is explicitly not a pain medication and should not be used to treat pain from other conditions unless specifically prescribed for those approved indications 2.

Why This Matters

Gout vs. General Musculoskeletal Pain

If the musculoskeletal pain is from an acute gout flare, colchicine is strongly recommended as first-line therapy alongside NSAIDs and corticosteroids 3, 1. The 2020 ACR guidelines and 2017 ACP guidelines both support colchicine for gout flares with high-quality evidence 3, 1.

Proper dosing for gout flares: 1.2 mg immediately followed by 0.6 mg one hour later, with ongoing therapy until flare resolves 3, 1.

Osteoarthritis Evidence

For osteoarthritis (the most common cause of musculoskeletal pain), colchicine does not work:

• A 2023 systematic review and meta-analysis found no clinically important pain reduction with colchicine compared to placebo in knee/hand OA (moderate-quality evidence) 4
• A 2021 RCT in hand OA showed colchicine was not effective for reducing pain, with no significant difference from placebo 5
• A 2018 RCT (COLKOA trial) demonstrated colchicine failed to improve symptoms in knee OA over 16 weeks, despite reducing some inflammatory markers 6
• A 2022 study found physical therapy was significantly more effective than colchicine for knee OA pain 7

The only positive trial was a small 2011 study 8, but this has been contradicted by multiple larger, higher-quality recent trials.

Safety Concerns

Colchicine carries significant risks that make empiric use for non-specific pain inappropriate 1, 2:

• Fatal overdoses have been reported in both adults and children
• Gastrointestinal toxicity: diarrhea, nausea, vomiting, abdominal pain (most common side effect)
• Neuromuscular toxicity: muscle pain/weakness, peripheral neuropathy
• Blood dyscrasias: bone marrow suppression, agranulocytosis, aplastic anemia
• Contraindicated in patients with renal or hepatic impairment taking CYP3A4 or P-glycoprotein inhibitors 1, 2
• Multiple dangerous drug interactions with antibiotics, antifungals, and antiretrovirals 2

Clinical Algorithm

When evaluating musculoskeletal pain:

1. Is this an acute gout flare? (monoarticular, sudden onset, severe pain, erythema, warmth, typically first MTP joint)

   • YES → Colchicine is appropriate (1.2 mg then 0.6 mg 1 hour later) 3, 1
   • NO → Proceed to step 2

2. Is this osteoarthritis or other non-inflammatory musculoskeletal pain?

   • YES → Do NOT use colchicine—use acetaminophen, NSAIDs, physical therapy, or other appropriate OA treatments 4, 5, 6
   • NO → Proceed to step 3

3. Is this familial Mediterranean fever?

   • YES → Colchicine is indicated 2
   • NO → Colchicine is not appropriate

Bottom Line

Colchicine should only be prescribed for its FDA-approved indications: gout flares and FMF. For general musculoskeletal pain or osteoarthritis, multiple high-quality recent trials demonstrate it is ineffective, and the risk-benefit ratio does not support its use 4, 5, 6. The drug's narrow therapeutic window, potential for fatal toxicity, and numerous drug interactions make off-label use for non-specific musculoskeletal pain medically inappropriate 2.